Sam Brusco, Associate Editor10.11.22
XACT Robotics has earned U.S. Food and Drug Administration (FDA) clearance for its ACE Xtend remote control unit. It allows users to robotically insert and steer the XACT ACE robotic system remotely from the control room.
The first-of-its-kind feature for CT-guided percutaneous procedures aims to help improve physician workflows while limiting exposure to radiation and reducing physical strain.
“The XACT ACE Robotic System has already allowed users to make percutaneous procedures, such as ablations, drainages and biopsies, more accurate, consistent and efficient,” Shai Meltzer, CEO of XACT Robotics told the press. “The addition of ACE Xtend has the potential to further increase efficiencies for the care team with a streamlined workflow that helps reduce the time in which physicians and other users are exposed to harmful radiation during standard procedures.”
“Interventional radiology is among the medical specialties that are facing a physician shortage in the coming years and technologies that can improve their efficiencies are crucial,” added Jeffrey Solomon, MD, VP of Medical Affairs at XACT. “By equipping different users with tools that can standardize the procedure and potentially shorten procedure times, we can maximize the number of patients they see and help to mitigate the gap between the patient population and the physician population.”
The XACT ACE robotic system combines image-based planning and monitoring with its patented S-Drive that enables quick adaptation from a linear to a non-linear trajectory with its robotic instrument insertion and steering during interventional percutaneous procedures.
The system has been proven to achieve 1.7mm tip to target average accuracy upon first insertion based on data gained from clinical studies for biopsies.
The first-of-its-kind feature for CT-guided percutaneous procedures aims to help improve physician workflows while limiting exposure to radiation and reducing physical strain.
“The XACT ACE Robotic System has already allowed users to make percutaneous procedures, such as ablations, drainages and biopsies, more accurate, consistent and efficient,” Shai Meltzer, CEO of XACT Robotics told the press. “The addition of ACE Xtend has the potential to further increase efficiencies for the care team with a streamlined workflow that helps reduce the time in which physicians and other users are exposed to harmful radiation during standard procedures.”
“Interventional radiology is among the medical specialties that are facing a physician shortage in the coming years and technologies that can improve their efficiencies are crucial,” added Jeffrey Solomon, MD, VP of Medical Affairs at XACT. “By equipping different users with tools that can standardize the procedure and potentially shorten procedure times, we can maximize the number of patients they see and help to mitigate the gap between the patient population and the physician population.”
The XACT ACE robotic system combines image-based planning and monitoring with its patented S-Drive that enables quick adaptation from a linear to a non-linear trajectory with its robotic instrument insertion and steering during interventional percutaneous procedures.
The system has been proven to achieve 1.7mm tip to target average accuracy upon first insertion based on data gained from clinical studies for biopsies.